Annual CFF
$14.44 M
+$9.01 M+165.82%
December 31, 2024
Summary
- As of March 12, 2025, AGIO annual cash flow from financing activities is $14.44 million, with the most recent change of +$9.01 million (+165.82%) on December 31, 2024.
- During the last 3 years, AGIO annual CFF has risen by +$780.21 million (+101.89%).
- AGIO annual CFF is now -97.36% below its all-time high of $546.02 million, reached on December 31, 2018.
Performance
AGIO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$4.84 M
+$2.21 M+83.62%
December 31, 2024
Summary
- As of March 12, 2025, AGIO quarterly cash flow from financing activities is $4.84 million, with the most recent change of +$2.21 million (+83.62%) on December 31, 2024.
- Over the past year, AGIO quarterly CFF has increased by +$4.00 million (+471.66%).
- AGIO quarterly CFF is now -99.08% below its all-time high of $528.28 million, reached on March 31, 2018.
Performance
AGIO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$14.44 M
+$4.00 M+38.24%
December 31, 2024
Summary
- As of March 12, 2025, AGIO TTM cash flow from financing activities is $14.44 million, with the most recent change of +$4.00 million (+38.24%) on December 31, 2024.
- Over the past year, AGIO TTM CFF has increased by +$9.01 million (+165.82%).
- AGIO TTM CFF is now -98.22% below its all-time high of $809.34 million, reached on March 31, 2018.
Performance
AGIO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
AGIO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +165.8% | +471.7% | +165.8% |
| 3 y3 years | +101.9% | +471.7% | +165.8% |
| 5 y5 years | -95.0% | +471.7% | +165.8% |
AGIO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +101.9% | -17.4% | +126.0% | at high | +101.9% |
| 5 y | 5-year | -95.0% | +101.9% | -98.3% | +101.0% | -97.3% | +101.9% |
| alltime | all time | -97.4% | +101.9% | -99.1% | +101.0% | -98.2% | +101.9% |
Agios Pharmaceuticals Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $14.44 M(+165.8%) | $4.84 M(+83.6%) | $14.44 M(+38.2%) |
| Sep 2024 | - | $2.64 M(+139.9%) | $10.45 M(+7.8%) |
| Jun 2024 | - | $1.10 M(-81.3%) | $9.69 M(+9.8%) |
| Mar 2024 | - | $5.86 M(+592.3%) | $8.83 M(+62.5%) |
| Dec 2023 | $5.43 M(+131.2%) | $847.00 K(-55.0%) | $5.43 M(+17.9%) |
| Sep 2023 | - | $1.88 M(+694.1%) | $4.61 M(+17.8%) |
| Jun 2023 | - | $237.00 K(-90.4%) | $3.91 M(+8.4%) |
| Mar 2023 | - | $2.47 M(>+9900.0%) | $3.61 M(+53.6%) |
| Dec 2022 | $2.35 M(-100.3%) | $22.00 K(-98.1%) | $2.35 M(-114.5%) |
| Sep 2022 | - | $1.19 M(-1871.6%) | -$16.26 M(-93.9%) |
| Jun 2022 | - | -$67.00 K(-105.5%) | -$268.43 M(-65.2%) |
| Mar 2022 | - | $1.21 M(-106.5%) | -$771.82 M(+0.8%) |
| Dec 2021 | -$765.77 M(-392.8%) | -$18.59 M(-92.6%) | -$765.77 M(+2.6%) |
| Sep 2021 | - | -$250.99 M(-50.1%) | -$746.60 M(+51.7%) |
| Jun 2021 | - | -$503.46 M(-7033.7%) | -$492.17 M(-286.9%) |
| Mar 2021 | - | $7.26 M(+1147.6%) | $263.39 M(+0.7%) |
| Dec 2020 | $261.52 M(-9.7%) | $582.00 K(-83.1%) | $261.52 M(-51.4%) |
| Sep 2020 | - | $3.45 M(-98.6%) | $538.54 M(+0.0%) |
| Jun 2020 | - | $252.10 M(+4581.6%) | $538.43 M(+85.6%) |
| Mar 2020 | - | $5.38 M(-98.1%) | $290.14 M(+0.2%) |
| Dec 2019 | $289.61 M(-47.0%) | $277.61 M(+8219.0%) | $289.61 M(+2124.2%) |
| Sep 2019 | - | $3.34 M(-12.4%) | $13.02 M(-23.0%) |
| Jun 2019 | - | $3.81 M(-21.6%) | $16.91 M(-25.2%) |
| Mar 2019 | - | $4.86 M(+378.3%) | $22.61 M(-95.9%) |
| Dec 2018 | $546.02 M | $1.02 M(-85.9%) | $546.02 M(-0.3%) |
| Sep 2018 | - | $7.22 M(-24.0%) | $547.60 M(+0.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2018 | - | $9.51 M(-98.2%) | $545.70 M(-32.6%) |
| Mar 2018 | - | $528.28 M(>+9900.0%) | $809.34 M(+183.9%) |
| Dec 2017 | $285.11 M(+67.9%) | $2.59 M(-51.4%) | $285.11 M(-0.5%) |
| Sep 2017 | - | $5.32 M(-98.1%) | $286.51 M(-35.5%) |
| Jun 2017 | - | $273.15 M(+6651.2%) | $444.42 M(+157.3%) |
| Mar 2017 | - | $4.05 M(+1.3%) | $172.72 M(+1.7%) |
| Dec 2016 | $169.78 M(+2564.0%) | $3.99 M(-97.6%) | $169.78 M(+1.6%) |
| Sep 2016 | - | $163.23 M(>+9900.0%) | $167.07 M(+2676.7%) |
| Jun 2016 | - | $1.45 M(+30.8%) | $6.02 M(+6.3%) |
| Mar 2016 | - | $1.11 M(-13.9%) | $5.66 M(-11.2%) |
| Dec 2015 | $6.37 M(-98.1%) | $1.29 M(-40.8%) | $6.37 M(-97.4%) |
| Sep 2015 | - | $2.17 M(+99.2%) | $244.15 M(+0.7%) |
| Jun 2015 | - | $1.09 M(-40.1%) | $242.34 M(-28.0%) |
| Mar 2015 | - | $1.82 M(-99.2%) | $336.40 M(+0.4%) |
| Dec 2014 | $335.16 M(+170.6%) | $239.06 M(>+9900.0%) | $335.16 M(+250.3%) |
| Sep 2014 | - | $367.00 K(-99.6%) | $95.68 M(-56.4%) |
| Jun 2014 | - | $95.15 M(>+9900.0%) | $219.54 M(+76.4%) |
| Mar 2014 | - | $582.00 K(-237.3%) | $124.44 M(+0.4%) |
| Dec 2013 | $123.88 M(>+9900.0%) | -$424.00 K(-100.3%) | $123.88 M(-0.4%) |
| Sep 2013 | - | $124.23 M(>+9900.0%) | $124.36 M(>+9900.0%) |
| Jun 2013 | - | $47.00 K(+88.0%) | $160.00 K(+24.0%) |
| Mar 2013 | - | $25.00 K(-53.7%) | $129.00 K(-9.2%) |
| Dec 2012 | $142.00 K(-99.8%) | $54.00 K(+58.8%) | $142.00 K(+61.4%) |
| Sep 2012 | - | $34.00 K(+112.5%) | $88.00 K(+63.0%) |
| Jun 2012 | - | $16.00 K(-57.9%) | $54.00 K(+42.1%) |
| Mar 2012 | - | $38.00 K | $38.00 K |
| Dec 2011 | $77.36 M | - | - |
FAQ
- What is Agios Pharmaceuticals annual cash flow from financing activities?
- What is the all time high annual CFF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals annual CFF year-on-year change?
- What is Agios Pharmaceuticals quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals quarterly CFF year-on-year change?
- What is Agios Pharmaceuticals TTM cash flow from financing activities?
- What is the all time high TTM CFF for Agios Pharmaceuticals?
- What is Agios Pharmaceuticals TTM CFF year-on-year change?
What is Agios Pharmaceuticals annual cash flow from financing activities?
The current annual CFF of AGIO is $14.44 M
What is the all time high annual CFF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high annual cash flow from financing activities is $546.02 M
What is Agios Pharmaceuticals annual CFF year-on-year change?
Over the past year, AGIO annual cash flow from financing activities has changed by +$9.01 M (+165.82%)
What is Agios Pharmaceuticals quarterly cash flow from financing activities?
The current quarterly CFF of AGIO is $4.84 M
What is the all time high quarterly CFF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high quarterly cash flow from financing activities is $528.28 M
What is Agios Pharmaceuticals quarterly CFF year-on-year change?
Over the past year, AGIO quarterly cash flow from financing activities has changed by +$4.00 M (+471.66%)
What is Agios Pharmaceuticals TTM cash flow from financing activities?
The current TTM CFF of AGIO is $14.44 M
What is the all time high TTM CFF for Agios Pharmaceuticals?
Agios Pharmaceuticals all-time high TTM cash flow from financing activities is $809.34 M
What is Agios Pharmaceuticals TTM CFF year-on-year change?
Over the past year, AGIO TTM cash flow from financing activities has changed by +$9.01 M (+165.82%)